$KalVista Pharmaceuticals, Inc.(KALV)$ 8-K - Current report Filed: 2018-07-31 AccNo: 0001564590-18-017996 Size: 8 MBItem 1.02: Termination of a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接